MENU
LGVN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Longeveron (LGVN) Ownership - Who owns Longeveron?

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions... Show more

Profile

Industry
N/A
Address
1951 NW 7th Avenue
Phone
+1 305 909-0840
Employees
25
Web
https://www.longeveron.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
15.56M
P/E Ratio
2.99
Total Cash
10.33M
Projected Growth
N/A
Total Debt
1.14M
Revenue
2.07M
Risk (Beta)
1.19
Dividend Yield
N/A
Total Cash/Share
0.50
Total Debt/Equity
N/A
Revenue/Share
0.14 USD as % of share price

Fundamentals

LGVN
Capitalization
15.6M
P/E Ratio
2.99
Risk (Beta)
1.19
Dividend Yield
N/A
Total Cash
10.3M
Total Cash/Share
0.50
Total Debt
1.14M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.14%
Revenue
2.07M
ROE
N/A
Book Value
12.7M
P/B Ratio
1.23
Cash Flow
N/A
Earnings
0.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
14K
Current Ratio
3.43
Current Revenue Per Employee
12640.00
Dividends Per Share - Security
N/A
EBITDA
-18.35M
Float
N/A
Float - Current
N/A
Gross Income Margin
46.20
Revenue To Assets
-103.43
Shares Held By Institutions
948K
Shares Outstanding - Current
20.8M
Total Liabilities
4.09M
Total Volume MTD
N/A
Value
1
Gain YTD
-56.757
View a ticker or compare two or three
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1951 NW 7th Avenue
Phone
+1 305 909-0840
Employees
25
Web
https://www.longeveron.com